Alpha 2.0
Login Register
» Authors » M T Nurmohamed

M T Nurmohamed

Explore the profile of M T Nurmohamed including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 116
Citations 2674
Followers 0
Related Specialties
Rheumatology
General Medicine
Hematology
Top 10 Co-Authors
B A C Dijkmans
I E van der Horst-Bruinsma
W F Lems
A E Voskuyl
M J L Peters
G J Wolbink
V P van Halm
J W Ten Cate
M Boers
J C van Denderen
Published In
Ann Rheum Dis
Scand J Rheumatol
Thromb Haemost
Rheumatol Int
Ned Tijdschr Geneeskd
Affiliations
Soon will be listed here.
Recent Articles
1.
Elevated neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are associated with increased flares and elevated cardiovascular disease risk in gout
Stultz R, Dai L, van Geel E, Gerritsen M, Nurmohamed M, Lood C
Scand J Rheumatol . 2025 Jan; 54(2):142-146. PMID: 39819380
Objective: Although gout is the most common inflammatory arthritis, there are few tools to monitor disease activity and predict complications in gout patients. The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio...
2.
Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors: A Longitudinal Study
Hansildaar R, Raadsen R, Gerritsen M, Nagy M, Dijkshoorn B, Spronk H, et al.
J Clin Rheumatol . 2024 Sep; 30(8):e166-e171. PMID: 39342416
Objectives: This study aims to investigate the activation of the coagulation system of RA patients and assess changes during anti-inflammatory treatment with tumor necrosis factor blockers (anti-TNF) and Janus kinase...
3.
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women
Raadsen R, Hansildaar R, van Kuijk A, Nurmohamed M
Semin Arthritis Rheum . 2023 Jun; 62:152233. PMID: 37356211
Background: Patients with rheumatoid arthritis (RA) are at an increased risk for developing cardiovascular diseases. While advice regarding cardiovascular risk screening and management in RA patients has been incorporated in...
4.
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study
van den Hoek J, Sobejana M, van Nes F, Metsios G, Kitas G, van der Leeden M, et al.
Rheumatol Int . 2023 Apr; 43(7):1369-1376. PMID: 37093275
The objective of the study was to gain an insight into the perceptions and experiences of patients with rheumatoid arthritis and a high cardiovascular disease risk (CVD-RA) when undergoing an...
5.
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis
Blanken A, Korteweg M, van Boheemen L, van Vollenhoven R, Nurmohamed M, van der Laken C
Scand J Rheumatol . 2023 Mar; 53(2):85-93. PMID: 36974977
Objective: To investigate the performance and factors of influence of optical spectral transmission (OST) imaging as a new technique for measuring joint inflammation in rheumatoid arthritis (RA). Method: OST was...
6.
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review
Sobejana M, van der Esch M, van den Hoek J, Kitas G, van der Leeden M, Nurmohamed M, et al.
Curr Rheumatol Rep . 2023 Mar; 25(4):69-81. PMID: 36867308
Purpose Of Review: In addition to disease-modifying anti-rheumatic drug (DMARD) treatment, exercise is increasingly promoted in patients with rheumatoid arthritis (RA). Although both are known to reduce disease activity, few...
7.
Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
Zwiep J, Bet P, Rhebergen D, Nurmohamed M, Vinkers C, Penninx B, et al.
Brain Behav Immun Health . 2023 Jan; 27:100585. PMID: 36655056
Introduction: As the role of (neuro)inflammation in depression pathophysiology is emerging, augmentation of antidepressant treatments with anti-inflammatory drugs have shown beneficial results, but not consistently across all studies. Inconsistencies may...
8.
Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis
Wiegel J, Seppen B, Nurmohamed M, Bos W, ter Wee M
BMC Rheumatol . 2022 Nov; 6(1):73. PMID: 36447263
Background: The use of frequent electronic patient reported outcome measures (ePRO's) enables monitoring disease activity at a distance (telemonitoring) in patients with inflammatory arthritis. However, telemonitoring studies report declining long-term...
9.
In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study
Raadsen R, Agca R, Boers M, van Halm V, Peters M, Smulders Y, et al.
Semin Arthritis Rheum . 2022 Nov; 58:152132. PMID: 36434892
Objectives: To extend our investigation of cardiovascular diseases (CVD) in rheumatoid arthritis (RA) patients to a follow up of more than 20 years, with a special focus on patients without...
10.
Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study
Sobejana M, van den Hoek J, Metsios G, Kitas G, van der Leeden M, Verberne S, et al.
Clin Rheumatol . 2022 Aug; 41(12):3725-3734. PMID: 36006555
Objective: In patients with rheumatoid arthritis (RA) with cardiovascular disease risk, it is unknown whether exercises are safe, improve cardiorespiratory fitness and reduce disease-related symptoms and cardiovascular-disease (CVD) risk factors....